Kingsview Wealth Management’s Sanofi SNY Stock Holding History

Kingsview Wealth Management’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$254K	Sell	5,958 -399	-6%	-$17.8K	﹤0.01%	1260
2026 Q1	$306K	Buy	6,357 +71	+1%	+$3.31K	﹤0.01%	1076
2025 Q4	$305K	Buy	6,286 +53	+0.9%	+$2.63K	﹤0.01%	1016
2025 Q3	$294K	Sell	6,233 -405	-6%	-$19.5K	﹤0.01%	969
2025 Q2	$321K	Buy	6,638 +702	+12%	+$35.9K	0.01%	913
2025 Q1	$329K	Buy	5,936 +55	+0.9%	+$2.98K	0.01%	857
2024 Q4	$284K	Sell	5,881 -20	-0.3%	-$1.02K	0.01%	923
2024 Q3	$340K	Buy	5,901 +794	+16%	+$42.9K	0.01%	841
2024 Q2	$248K	Buy	+5,107	New	+$246K	0.01%	912

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Kingsview Wealth Management's SNY Position: Q2 2026 in Review

Kingsview Wealth Management reduced its Sanofi (SNY) stake by 6.3% in Q2 2026, selling an estimated $17.8K and leaving 5,958 shares worth $254K. The position accounts for ﹤0.01% of the portfolio, ranked #1260.

Kingsview Wealth Management first reported a position in SNY in Q2 2024 and has held it in 9 quarters since. The position peaked at $340K in Q3 2024. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

Kingsview Wealth Management held 5,958 shares of Sanofi worth $254K as of Q2 2026.
Kingsview Wealth Management sold 399 Sanofi shares in Q2 2026, an estimated $17.8K.
Sanofi made up ﹤0.01% of Kingsview Wealth Management's portfolio in Q2 2026, its #1260 holding.
Kingsview Wealth Management first reported a position in Sanofi in Q2 2024 and has held it in 9 quarters since.
Kingsview Wealth Management's Sanofi position peaked at $340K in Q3 2024.
716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Kingsview Wealth Management's 13F filing for Q2 2026, filed 19 Aug 2026.